Home
HelpTest Code BUPRE BUPRENORPHINE SCREEN WITH LC-MS/MS CONFIRMATION, URINE (BASED ON POSITIVE SCREEN)
Additional Codes
| Software | Test Code |
|---|---|
| SoftID | BUPRE |
| EPIC | LAB10906 |
Performing Laboratory
NorDx Laboratories
Useful For
A screening assay to detect buprenorphine in urine
Method Name
Cloned Enzyme Donor Immunoassay (CEDIA)
Liquid Chromatography-Tandem Mass Spectrometry (LC-MC/MS) (If indicated)
Reference Values
Not Detected
The presence of buprenorphine at 5 ng/mL or norbuprenorphine at 5 ng/mL is a strong indicator that the patient has used buprenorphine.
For help with interpretation please call: 877-323-0045
Please see test code BUPMT for additional buprenorphine confirmatory testing information.
Days and Times Test Performed
Monday through Friday
Report Available
1 Day
Specimen Type
Urine, Random
Preferred Container
Urine Cup
Preferred Volume
Urine, Random: 25 mL (Urine Cup)
Minimum Volume
Urine, Random: 10 mL (Urine Cup)
Specimen Collection and Handling
Collect random urine and send refrigerated in a clean, non-sterile urine container.
Specimen Stability Information
Specimen Type: Urine, Random
Frozen: 30 Days
Refrigerated: 7 Days
Room Temp: 2 Days
Add On Capable
Not Permitted
Advance Beneficiary Notice Requirements
This test, when ordered on Medicare patients, is subject to the National Coverage Determination (NCD) policies. Please verify that the diagnosis code (ICD code) you have chosen demonstrates medical necessity for the test as documented in the physician’s patient record. The CMS web site is available to assist you with this verification. A properly executed Advance Beneficiary Notice (ABN) must be submitted with the specimen if medical necessity is not demonstrated by the ICD code chosen.
CPT Code Information
|
CPT Code |
CPT Description |
CPT Disclaimer |
|---|---|---|
| 80307 | Drug Test, Presumptive Screening, By Instrument Chemistry (i.e Immunoassay, Chromatography, and Mass Spectrometry) | |
| 80307 | Drug Test, Presumptive Screening, By Instrument Chemistry (i.e Immunoassay, Chromatography, and Mass Spectrometry) | |
| 80348 | Buprenorphine (Definitive), Quantitative | if Indicated |
Keywords
SUBOXONE
SUBUTEX
Performing Laboratory Location
NorDx Laboratories
Maximum Laboratory Time
4 Days
LOINC Code Information
3414-0
Clinical Significance
If the buprenorphine screen is >5 ng/mL (positive), buprenorphine confirmation/quantitation by LC-MS/MS is performed at an additional charge.
This test is intended for clinical monitoring and management of patients. It is not intended for non-medical use such as employment of forensic testing.
INTENDED POSITIVES:
Buprenorphine (Suboxone, Subutex)